(57 days)
No
The description focuses on the mechanical and structural features of a steerable catheter introducer and does not mention any AI or ML capabilities.
No
The device is an introducer used to facilitate the placement of other cardiovascular catheters; it does not directly treat a medical condition itself.
No
The device is described as an "introducer" for various cardiovascular catheters, facilitating their entry into the heart. Its function is to steer and guide other catheters, not to perform diagnostic measurements or analyses itself. While it mentions pressure monitoring via a sideport, its primary role is not diagnostic.
No
The device description clearly describes a physical catheter introducer with various hardware components (sheath, valve, sideport, dilator, guidewire) and is used for introducing other physical catheters into the heart.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
- Device Function: The Agilis™ NxT Steerable Introducer is a medical device used to introduce other catheters into the heart. It is a tool used during a medical procedure on a patient's body, not a test performed on a sample outside the body.
- Intended Use: The intended use clearly states it's for "introducing various cardiovascular catheters into the heart." This is an in-vivo (within the living body) procedure.
- Device Description: The description details a physical device with features for navigation and access within the body (steerable tip, hemostasis valve, sideport, radiopaque material).
- Lack of IVD Characteristics: There is no mention of analyzing biological samples, detecting biomarkers, or providing diagnostic information based on laboratory testing.
Therefore, based on the provided information, the Agilis™ NxT Steerable Introducer is a surgical/interventional medical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Agilis NxT Steerable Introducer is indicated for introducing marious cardiovascular catheters into the heart, including the left side of the heart through the interatrial septum.
Product codes
DYB
Device Description
The Agilis™ device is an 8.5 F steerable catheter introducer. The device has a small curl or medium curl at the distal tip which can deflect 90° in the counterclockwise direction and 180° in the clockwise direction. The device is indicated for introducing various cardiovascular catheters into the heart, including the left side of the heart through the interatrial septum. The proximal end of the device is fitted with a hemostasis valve to minimize blood loss during catheter introduction and exchange over a guidewire. A sideport with a three-way store can is provided for air or blood aspiration, fluid infusion, blood sampling, and pressure monitoring. The sheath is filled with radiopaque material for visualization under fluoroscopy. A plastic dilator and stainless steel guidewire are packaged with the introducer and are designed to facilitate the introduction and passage of the introducer through the vasculature.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
heart, interatrial septum
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Testing has demonstrated that the new device is substantially equivalent to the predicate devices.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1340 Catheter introducer.
(a)
Identification. A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.(b)
Classification. Class II (performance standards).
0
. 510(k) SUMMARY
K06/363
| Submitter's Name: | St. Jude Medical | |
|---|---|---|
| Address: | 14901 DeVeau Place | |
| Minnetonka, MN 55345 | JUL 1 2 200 | |
| Tel: | 952-933-4700 | |
| Fax: | 952-930-9481 | |
| Contact Person: | Glenn Jacques | |
| Date of Summary Preparation: | May 15, 2006 | |
| Device Common Name: | Introducer, Catheter | |
| Device Trade Name: | Agilis NxT Steerable Introducer | |
| Device Classification Name: | 21 CFR 870.1340 | |
| Classification: Class II | ||
| Product Code: DYB | ||
| Predicate Devices: | Agilis Steerable Catheter Introducer | |
| K042623 | ||
| Livewire Electrophysiology Diagnostic Catheter | ||
| K022380 |
Device Description
The Agilis™ device is an 8.5 F steerable catheter introducer. The device has a small curl or medium curl at the distal tip which can deflect 90° in the counterclockwise direction and 180° in the clockwise direction. The device is indicated for introducing various cardiovascular catheters into the heart, including the left side of the heart through the interatrial septum. The proximal end of the device is fitted with a hemostasis valve to minimize blood loss during catheter introduction and exchange over a guidewire. A sideport with a three-way store can is provided for air or blood aspiration, fluid infusion, blood sampling, and pressure monitoring. The sheath is filled with radiopaque material for visualization under fluoroscopy. A plastic dilator and stainless steel guidewire are packaged with the introducer and are designed to facilitate the introduction and passage of the introducer through the vasculature.
Indications for Use
The Agilis™ NxT Steerable Introducer is indicated for introducing various cardiovascular catheters into the heart, including the left side of the heart through the interatrial septum.
1
Comparison to Predicate Device
The Agilis NxT introducer has similar design, materials, and technical requirements as the predicate devices.
Summary of Testing
Testing has demonstrated that the new device is substantially equivalent to the predicate devices.
Conclusion
The proposed modifications are equivalent to the predicates with respect to intended use, technological characteristics, and performance specifications.
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS). The seal features the department's name in a circular arrangement around a symbol. The symbol consists of a stylized caduceus, which is a staff with two snakes entwined around it, representing medicine and health.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 1 2 2006
St. Jude Medical, Inc. c/o Mr. Glenn Jacques Manager, Regulatory Affairs 14901 DeVeau Place Minnetonka, MN 55345
Re: K061363 Agilis NxT Steerable Introducer Regulation Number: 21 CFR 870.1340 Regulation Name: Introducer Catherter Regulatory Class: II Product Code: DYB Dated: June 19, 2006 Received: June 20, 2006
Dear Mr. Jacques:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Glenn Jacques
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
h
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE
K 061363
510(k) Number:
Device Name:
Agilis NxT Steerable Introducer
. .
Indications for Use: The Agilis NxT Steerable Introducer is indicated for introducing marious cardiovascular catheters into the heart, including the left side of the heart through the interatrial septum.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
h
sion Sabit - H
510(k) Number
33